午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
Aladdin Scientific Company Information
Company Name:
Aladdin Scientific
Tel:
-
Email:
tp@aladdinsci.com
Nationality:
United States
WebSite:
www.aladdinsci.com/
Product List:
52924
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
Product List
Oxytocin parallel dimer
19645-28-4
α-Obscurine
596-55-4
O-Desmethyl Mebeverine alcohol hydrochloride
856620-39-8
ODM-207
1801503-93-4
OXFBD04
2231747-03-6
18-Oxocortisol
2410-60-8
O1-benzyl O3-methyl (3S)-piperidine-1,3-dicarboxylate
88466-73-3
Obeldesivir
2647441-36-7
Olacaftor
1897384-89-2
OPC-14523 hydrochloride
145969-31-9
Olaparib-d5
2143107-56-4
Oxotremorine M iodide
3854-04-4
2'-O-Methylisoliquiritigenin
51828-10-5
3-[tert-butyl(diphenyl)silyl]oxy-2,2-dimethyl-propanoic acid
480450-04-2
ODN D-SL03
1198621-85-0
Oxyntomodulin
62340-29-8
3-O-Methyldopa-d3
586954-09-8
Osimertinib-d6
1638281-44-3
Org41841
301847-37-0
OSIP-486823
200803-37-8
[Asp5]-Oxytocin
65907-78-0
Obtusin
70588-05-5
Okanin
484-76-4
ONO-8430506
1354805-08-5
OT-R antagonist 1
364071-17-0
5'-O-DMT-N4-Bz-5-Me-dC
104579-03-5
ORM-15341
1297537-33-7
Org-26576
100044-96-0
ODN 1668
1186063-66-0
Onjisaponin B
35906-36-6
2-[tert-butyl(dimethyl)silyl]oxy-2-(5-fluoro-2-pyridyl)ethanol
2816913-53-6
Oglufanide
38101-59-6
Odapipam
131796-63-9
ODN 2007
455348-63-7
3-oxa-8-azabicyclo[3.2.1]octan-1-ylmethanol;hydrochloride
2643374-51-8
Omiganan
204248-78-2
Oxyresveratrol 2-O-β-D-glucopyranoside
392274-22-5
ODN 24991
1682661-49-9
Omidenepag isopropyl
1187451-19-9
Omeprazole-d3-1
934293-92-2
OVA Peptide(257-264) TFA
1262751-08-5
OTS193320
2093401-33-1
Odiparcil
137215-12-4
ORM-10962
763926-98-3
Oseltamivir-acetate
1191921-01-3
(R)-Olacaftor
1899111-41-1
Oleic acid-d2
5711-29-5
ONO-0300302
856689-51-5
2-O-Acetyl-20-hydroxyecdysone
19536-25-5
Odronextamab
1801338-64-6
Osteogenic Growth Peptide (10-14)
105250-85-9
Orexin receptor antagonist 3
1293282-55-9
4-O-Methyl honokiol
68592-15-4
4-oxo-3,4-dihydrophthalazine-1-carboxylic acid
3260-44-4
Osilodrostat phosphate
1315449-72-9
OTSSP167 hydrochloride
1431698-10-0
Olumacostat glasaretil
1261491-89-7
(Thr4,Gly7)-Oxytocin
60786-59-6
Olmesartan-d4
1420880-41-6
Omadacycline hydrochloride
1196800-39-1
ODN 2395
1254617-22-5
ODN 1018
937402-51-2
Oroxylin A-7-O-glucuronide
36948-76-2
OVA-E1 peptide TFA
1262750-80-0
OM-153
2406278-81-5
OT-R antagonist 2
364071-16-9
ODN 2216
332437-00-0
Orexin 2 Receptor Agonist
1796565-52-0
Oritavancin diphosphate
192564-14-0
Olcegepant hydrochloride
586368-06-1
OVA Peptide (323-339)
92915-79-2
Oteseconazole
1340593-59-0
O6-tert-butyl O7-methyl 2,2-difluoro-6-azaspiro[3.4]octane-6,7-dicarboxylate
2797494-25-6
Orotidine 5′-monophosphate trisodium
68244-58-6
(2R)-Octyl-α-hydroxyglutarate
1391194-67-4
6-oxo-3-azabicyclo[3.2.0]heptane-2-carboxylic acid;2,2,2-trifluoroacetic acid
2821030-52-6
O3-benzyl O1-tert-butyl 4,4-dimethylpyrrolidine-1,3-dicarboxylate
2816914-17-5
306Oi10
2322290-93-5
Oritinib
2035089-28-0
4'-O-Methylbavachalcone
20784-60-5
ODN 1585
386832-46-8
ODN 1826
202668-42-6
Omapatrilat
167305-00-2
(S)-Osanetant
182621-58-5
4-oxocyclohexane-1,1-dicarboxylic acid
58230-12-9
Orexin 2 Receptor Agonist 2
2114324-60-4
ODN 2336
332956-64-6
O6-tert-butyl O8-ethyl 2-hydroxy-6-azaspiro[3.4]octane-6,8-dicarboxylate
2865115-28-0
OF-C4-Deg-Lin
2383003-60-7
ON-013100
865783-95-5
ORIC-101
2222344-98-9
6-O-Propynyl-2'-deoxyguanosine
1640051-47-3
Opiranserin hydrochloride
1440796-75-7
Oxyphyllacinol
87657-77-0
ODN 20844
1964506-29-3
OTS447
1356943-67-3
4-oxo-3-azaspiro[5.5]undecane-11-carboxylic acid;hydrochloride
2740387-42-0
5'-O-TBDMS-dA
51549-30-5
1-(iodomethyl)-7-oxabicyclo[2.2.1]heptane
946402-76-2
ONO-0740556
2250210-69-4
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
Copyright 2007© ChemicalBook. All rights reserved.